This protective effect might be mediated by CMV-driven expansion of donor-derived memory-like NKG2C + and NKG2D + natural killer cells, NKp46 cells, CD8 + T cells, and γ/δ T cells to intensify the graft-versus-lymphoma (GVL) effect [34–37]. The gene discussed is KLRC2; the disease is lymphoma.